[Duhring-Brocq disease controlled for six months by small doses of sulfapyridine; leukopenia, with violent recurrence of the eruption on abandonment of the therapy].
D003874:Dermatitis Herpetiformis / Q000628:therapy*; D005076:Exanthema; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013427:Sulfapyridine; D013449:Sulfonamides / Q000627:therapeutic use*
D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D013427:Sulfapyridine
DERMATITIS HERPETIFORMIS/therapy; LEUKOCYTE COUNT; SULFONAMIDES/therapeutic use
Maladie de Dühring-Brocq jugulée pendant 6 mois par petites doses de sulfapyridine; leucopénie; reprise violente de l'éruption par abandon du traitement.